Opioid Prevention Grants
86 active federal grants matching "opioid". Updated daily.
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-28-013
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-RM-27-007
NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)
HHS-NIH11 · RFA-AR-28-001
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-RM-27-016
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-RM-27-025
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-HL-27-010
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-DA-28-013
Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)
HHS-NIH11 · RFA-HG-27-010
Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HG-27-007
Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HG-27-009
IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
HHS-NIH11 · RFA-HG-27-008
OJJDP FY 2026 Opioid Affected Youth Initiative
USDOJ-OJP-OJJDP · O-OJJDP-2026-172748
OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use
USDOJ-OJP-OJJDP · O-OJJDP-2026-172743
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-RM-27-024
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)
HHS-NIH11 · RFA-DA-28-012
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
HHS-NIH11 · RFA-DA-28-011
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
HHS-NIH11 · RFA-AI-27-018
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-AI-28-031
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-NS-28-010
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-MH-27-125
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-27-045
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-28-072
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-28-057
BJA FY 2026 Tribal Justice Training and Technical Assistance Program
USDOJ-OJP-BJA · O-BJA-2026-172727
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
HHS-NIH11 · PAR-28-056
About Opioid Prevention Grants
The federal government funds opioid programs through competitive grants posted on Grants.gov. Eligible applicants typically include 501(c)(3) nonprofits, state/local governments, tribal organizations, and educational institutions. Applications usually require a project narrative, budget justification, and evidence of organizational capacity. New opportunities post year-round with 30-60 day application windows.